Sinopharm Medical: Revenue of 525 million yuan in 2025, a year-on-year increase in net profit of 3057.05%.

Sinovac Medical announced that in 2025, the total operating income was 525.4079 million yuan, an increase of 14.53% year-on-year; the net profit attributable to the owners of the parent company was 47.2863 million yuan, an increase of 3,057.05% year-on-year; the non-net profit was 33.9555 million yuan, an increase of 293.82% year-on-year. The significant increase in net profit was due to the continuous growth of revenue, the decrease in costs and some expenses, and the low base of the previous year. At the end of the reporting period, the total assets were 1,349.6685 million yuan, an increase of 3.78% from the end of the previous year; the equity attributable to the owners of the parent company was 927.6449 million yuan, an increase of 7.01%. The data is preliminary and may differ from the annual report.